OBJECTIVE. We describe the significance of detecting focal areas of hypermetabolism in the breast in patients undergoing PET/CT for reasons other than for breast cancer detection or staging. CONCLUSION. When evaluated, almost all of the abnormal foci detected in the… Read More
Imaging to Cure Cancer: Valuable Contribution of Radiology for Clinical Trial Success
Written by Dr. Ron Korn, Founder, Chairman and Chief Medical Officer at Imaging Endpoints
“I keep dreaming of a future, a future with a long and healthy life, not lived in the shadow of cancer but in the light” – Patrick Swayze
Introduction
Pancreatic cancer is one of the most lethal malignancies. It is often found late after the disease has spread throughout the body because it doesn’t cause symptoms until the disease has grown large. In fact, up to half of all patients with pancreatic cancer are found during an emergency room visit for sudden onset of jaundice (yellowing of eyes and skin). This usually prompts the treating physician to order a CT scan to look for a pancreatic tumor that may be causing the symptoms.
Industrial Development Authority of Scottsdale awards funding to Scottsdale Healthcare Research Institute
A one-of-a-kind rapid cancer detection program developed through collaboration between local physicians, the Scottsdale Healthcare Research Institute and Virginia G. Piper Cancer Center at Scottsdale Healthcare has been awarded a $100,000 grant from the Industrial Development Authority (IDA) of Scottsdale.
The Rapid Detection and Assessment of Response (RADAR) program uses high-tech radiologic imaging and advanced analysis to quickly assess whether a tumor is responding to treatment. RADAR provides physicians with information to make timely decisions about a treatment’s effectiveness and whether an alternate treatment is appropriate, according to Ronald Korn, M.D., PhD., medical director of Scottsdale Healthcare’s Virginia G. Piper Cancer Center.
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
